Table 1.
Lung | Colorectal | Breast | Prostate | |||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Cancer (n=55) | Benign (n=35) | Normal (n=53) | Cancer (n=31) | Benign (n=33) | Normal (n=52) | Cancer (n=53) | Benign (n=40) | Normal (n= 49) |
Cancer (n=65) | Benign (n=51) | Normal (n=74) | |
Sex | ||||||||||||
Male | 31 | 19 | 24 | 17 | 17 | 30 | 65 | 51 | 74 | |||
Female | 24 | 16 | 29 | 14 | 16 | 22 | 53 | 40 | 49 | |||
Race | ||||||||||||
Caucasian | 53 | 34 | 50 | 20 | 24 | 34 | 50 | 40 | 42 | 35 | 26 | 43 |
Noncaucasian | 2 | 1 | 3 | 11 | 9 | 18 | 3 | 7 | 30 | 25 | 31 | |
Age*, yr | ||||||||||||
Median | 67.42 | 59.74 | 60.06 | 63.71 | 59.62 | 59.06 | 53.04 | 47.27 | 60.78 | 62.01 | 65.22 | 62.14 |
Range | 48-88 | 20-80 | 49-82 | 35-79 | 47-80 | 48-77 | 33-84 | 22-83 | 48-84 | 45-79 | 50-79 | 50-74 |
Tumor stage | ||||||||||||
Stage 1 | 43 | 26 | 19 | 37 | ||||||||
Stage 2 | 12 | 5 | 34 | 28 |